← العودة إلى الصفحة الرئيسية
أوقيانوسيا · الأسواق الإقليمية · Stockhead

Orthocell partner receives US FDA clearance for marine-derived bone graft

نشره Stockhead · أستراليا منذ 1 س

Perth-based Orthocell has finalised a strategic investment in Marine Biomedical in January 2026, increasing its equity interest to 12% for ... Read More The post Orthocell partner…

اقرأ المقال كاملًا على Stockhead سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (stockhead.com.au)

يستحق القراءة أيضًا

The Motley Fool Australia

Uranium price tipped to rise 38%. Here's why and the ASX shares brokers rate a buy

 Business News (WA)

Westbridge buys $43m QLD medical asset

 Money Magazine

You don't need to miss a payment to get help

 ABC Business

North Korea denies role in Binance heist as customers withdraw billions

 Fat Tail Daily

Carry It Like Makybe

 Financial Standard

IFM Investors appoints global product strategy head